» Articles » PMID: 24846449

Vitamin D and Cognitive Function and Dementia Risk in a Biracial Cohort: the ARIC Brain MRI Study

Overview
Journal Eur J Neurol
Publisher Wiley
Specialty Neurology
Date 2014 May 22
PMID 24846449
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Some recent studies in older, largely white populations suggest that vitamin D, measured by 25-hydroxyvitamin D [25(OH)D], is important for cognition, but such results may be affected by reverse causation. Measuring 25(OH)D in late middle age before poor cognition affects behavior may provide clearer results.

Methods: This was a prospective cohort analysis of 1652 participants (52% white, 48% black) in the Atherosclerosis Risk in Communities (ARIC) Brain MRI Study. 25(OH)D was measured from serum collected in 1993-1995. Cognition was measured by the delayed word recall test (DWRT), the digit symbol substitution test (DSST) and the word fluency test (WFT). Dementia hospitalization was defined by ICD-9 codes. Adjusted linear, logistic and Cox proportional hazards models were used.

Results: Mean age of participants was 62 years and 60% were female. Mean 25(OH)D was higher in whites than blacks (25.5 vs. 17.3 ng/ml, P < 0.001). Lower 25(OH)D was not associated with lower baseline scores or with greater DWRT, DSST or WFT decline over a median of 3 or 10 years of follow-up (P > 0.05). Over a median of 16.6 years, there were 145 incident hospitalized dementia cases. Although not statistically significant, lower levels of 25(OH)D were suggestive of an association with increased dementia risk [hazard ratio for lowest versus highest race-specific tertile: whites 1.32 (95% confidence interval 0.69, 2.55); blacks 1.53 (95% confidence interval 0.84, 2.79)].

Conclusions: In contrast to prior studies performed in older white populations, our study of late middle age white and black participants did not find significant associations between lower levels of 25(OH)D with lower cognitive test scores at baseline, change in scores over time or dementia risk.

Citing Articles

Follow-Up Period Affects the Association between Serum 25-Hydroxyvitamin D Concentration and Incidence of Dementia, Alzheimer's Disease, and Cognitive Impairment.

Grant W Nutrients. 2024; 16(18).

PMID: 39339811 PMC: 11435265. DOI: 10.3390/nu16183211.


The Influence of Vitamin D Status on Cognitive Ability in Patients with Bipolar Disorder and Healthy Controls.

Leser B, Dalkner N, Tmava-Berisha A, Fellendorf F, Unterrainer H, Stross T Nutrients. 2023; 15(19).

PMID: 37836395 PMC: 10574501. DOI: 10.3390/nu15194111.


Is There a Role of Vitamin D in Alzheimer's Disease?.

Plantone D, Pardini M, Caneva S, De Stefano N CNS Neurol Disord Drug Targets. 2023; 23(5):545-553.

PMID: 37246320 DOI: 10.2174/1871527322666230526164421.


Association between vitamin D concentration and delirium in hospitalized patients: A meta-analysis.

Fu N, Miao M, Li N, Zeng S, Zhu R, Zhang J PLoS One. 2023; 18(2):e0281313.

PMID: 36753475 PMC: 9907811. DOI: 10.1371/journal.pone.0281313.


Low Serum Vitamin D Status Is Associated with Incident Alzheimer's Dementia in the Oldest Old.

van Lent D, Egert S, Wolfsgruber S, Kleineidam L, Weinhold L, Wagner-Thelen H Nutrients. 2023; 15(1).

PMID: 36615719 PMC: 9824107. DOI: 10.3390/nu15010061.


References
1.
Berger C, Greene-Finestone L, Langsetmo L, Kreiger N, Joseph L, Kovacs C . Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels. J Bone Miner Res. 2012; 27(6):1381-9. PMC: 5101062. DOI: 10.1002/jbmr.1587. View

2.
Alonso A, Mosley Jr T, Gottesman R, Catellier D, Sharrett A, Coresh J . Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study. J Neurol Neurosurg Psychiatry. 2009; 80(11):1194-201. PMC: 2783764. DOI: 10.1136/jnnp.2009.176818. View

3.
Pugliese G, Solini A, Bonora E, Orsi E, Zerbini G, Giorgino F . The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes. Atherosclerosis. 2011; 218(1):194-9. DOI: 10.1016/j.atherosclerosis.2011.04.035. View

4.
Michos E, Melamed M . Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care. 2007; 11(1):7-12. DOI: 10.1097/MCO.0b013e3282f2f4dd. View

5.
Kasahara A, Singh R, Noymer A . Vitamin D (25OHD) Serum Seasonality in the United States. PLoS One. 2013; 8(6):e65785. PMC: 3689782. DOI: 10.1371/journal.pone.0065785. View